# VERKAZIA
> **NDA214965** · New Drug Application · Sponsor: HARROW EYE · Approved 2021-06-23
## Drug
- **FDA Application Number:** NDA214965
- **Application type:** New Drug Application
- **Brand name:** VERKAZIA
- **Generic name:** CYCLOSPORINE
- **Active ingredients:** CYCLOSPORINE
- **Dosage form:** EMULSION
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** HARROW EYE
- **Manufacturer:** Harrow Eye, LLC
- **First approval:** 2021-06-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214965)
---
*AI Analytics · CC0 1.0*